JNJ

188.94

+1.67%↑

ABT

124.53

-0.36%↓

TMO

560.5

-0.93%↓

ISRG

531.35

-1.39%↓

DHR

216.24

-0.08%↓

JNJ

188.94

+1.67%↑

ABT

124.53

-0.36%↓

TMO

560.5

-0.93%↓

ISRG

531.35

-1.39%↓

DHR

216.24

-0.08%↓

JNJ

188.94

+1.67%↑

ABT

124.53

-0.36%↓

TMO

560.5

-0.93%↓

ISRG

531.35

-1.39%↓

DHR

216.24

-0.08%↓

JNJ

188.94

+1.67%↑

ABT

124.53

-0.36%↓

TMO

560.5

-0.93%↓

ISRG

531.35

-1.39%↓

DHR

216.24

-0.08%↓

JNJ

188.94

+1.67%↑

ABT

124.53

-0.36%↓

TMO

560.5

-0.93%↓

ISRG

531.35

-1.39%↓

DHR

216.24

-0.08%↓

Search

Quidel Corp

Abierto

27.06 -3.56

Resumen

Variación precio

24h

Actual

Mínimo

26.75

Máximo

28.38

Métricas clave

By Trading Economics

Empleados

6,600

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+41.37% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

300M

1.7B

Apertura anterior

30.62

Cierre anterior

27.06

Quidel Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

29 oct 2025, 23:28 UTC

Acciones populares

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

29 oct 2025, 23:07 UTC

Ganancias

Prudential PLC 3Q New Business Profit Up 13%

30 oct 2025, 00:00 UTC

Ganancias

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

30 oct 2025, 00:00 UTC

Ganancias

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

30 oct 2025, 00:00 UTC

Ganancias

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

29 oct 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

29 oct 2025, 23:40 UTC

Ganancias

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

29 oct 2025, 23:38 UTC

Charlas de Mercado

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

29 oct 2025, 23:25 UTC

Ganancias

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

29 oct 2025, 22:51 UTC

Ganancias

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

29 oct 2025, 22:45 UTC

Ganancias

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

29 oct 2025, 22:41 UTC

Ganancias

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

29 oct 2025, 22:41 UTC

Ganancias

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

29 oct 2025, 22:09 UTC

Ganancias

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

29 oct 2025, 22:08 UTC

Charlas de Mercado
Ganancias

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

29 oct 2025, 21:58 UTC

Ganancias

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

29 oct 2025, 21:58 UTC

Ganancias

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

29 oct 2025, 21:57 UTC

Ganancias

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

29 oct 2025, 21:54 UTC

Ganancias

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

29 oct 2025, 21:46 UTC

Ganancias

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

29 oct 2025, 21:43 UTC

Ganancias

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

29 oct 2025, 21:43 UTC

Ganancias

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

29 oct 2025, 21:42 UTC

Ganancias

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

29 oct 2025, 21:42 UTC

Ganancias

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

29 oct 2025, 21:41 UTC

Ganancias

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

29 oct 2025, 21:41 UTC

Ganancias

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

29 oct 2025, 21:41 UTC

Ganancias

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

29 oct 2025, 21:41 UTC

Ganancias

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

29 oct 2025, 21:40 UTC

Ganancias

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

29 oct 2025, 21:39 UTC

Ganancias

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Comparación entre iguales

Cambio de precio

Quidel Corp Esperado

Precio Objetivo

By TipRanks

41.37% repunte

Estimación a 12 meses

Media 39.5 USD  41.37%

Máximo 62 USD

Mínimo 26 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Quidel Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

4

Comprar

3

Mantener

1

Vender

Finanzas

$

Acerca de Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat